Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
14 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NAPROXEN SODIUM | 275MG | TABLET | Actual shortage | 2025-06-27 | 2025-12-04 | 261268 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2020-04-03 | 2020-04-09 | 110752 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118954 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2021-01-22 | 2021-03-18 | 132257 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2022-05-05 | 2022-06-04 | 160072 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2023-10-19 | 2023-11-09 | 207509 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2025-04-24 | 2025-08-21 | 255684 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2025-09-25 | 2025-11-20 | 267865 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Actual shortage | 2025-12-04 | 2025-12-04 | 273271 |
| TEVA-NARATRIPTAN | 1MG | TABLET | Resolved | 2017-03-13 | 2018-03-14 | 1038 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2017-03-13 | 2018-03-14 | 1137 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2020-07-23 | 2020-09-17 | 120884 |
| TEVA-NARATRIPTAN | 1MG | TABLET | Resolved | 2020-11-19 | 2021-01-21 | 128632 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2021-06-10 | 2021-07-15 | 140669 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2022-04-08 | 2022-06-17 | 158428 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2022-04-21 | 2022-06-03 | 159204 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2022-09-07 | 2022-10-01 | 168737 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2023-02-09 | 2023-02-16 | 184207 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2023-06-08 | 2023-08-18 | 194131 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2023-06-19 | 2023-07-06 | 195487 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |
| TEVA-OLMESARTAN / HCTZ | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| TEVA-OLMESARTAN / HCTZ | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| TEVA-OLMESARTAN / HCTZ | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258417 |
| ACT QUETIAPINE | 300MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258643 |
| ACT QUETIAPINE | 200MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258648 |
| ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
| ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
| ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |